Evidence map›Paper›PMID 24367038›Full record

ArticleThe Journal of infectious diseases2014

Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks.

Stephanie B Troy, Leticia Ferreyra-Reyes, Chunhong Huang, Clea Sarnquist, Sergio Canizales-Quintero, Christine Nelson, Renata Báez-Saldaña, Marisa Holubar, Elizabeth Ferreira-Guerrero, Lourdes García-García and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Trial
  2. Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Trial
  3. Mucosal immunity to poliovirus.Mucosal immunology · 2022
    Review
  4. Article
  5. Article
  6. Vaccination againstInfection and immunity · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Stephanie B TroyEastern Virginia Medical School, Norfolk, Virginia.
Leticia Ferreyra-Reyes
Chunhong Huang
Clea Sarnquist
Sergio Canizales-Quintero
Christine Nelson
Renata Báez-Saldaña
Marisa Holubar
Elizabeth Ferreira-Guerrero
Lourdes García-García
Yvonne A Maldonado
Instituto Nacional de Salud Pública · MXStanford University · USEastern Virginia Medical School · US

Funding

Global Epidemiology of Infectious DiseasesT32AI052073 · NIAID · STANFORD UNIVERSITY · PI Angelle Desiree LaBeaud, Stephen Patrick Luby · 2003 to 2026
$4.2M
Oral Polio Vaccine Circulation in MexicoK23AI093678 · NIAID · EASTERN VIRGINIA MEDICAL SCHOOL · PI TROY, STEPHANIE B · 2011 to 2014
$507k
NIAID NIH HHS 5K23AI093678NIAID NIH HHS K23 AI093678NIAID NIH HHS T32 AI052073
6 · The paper itself

Abstract

backgroundWith wild poliovirus nearing eradication, preventing circulating vaccine-derived poliovirus (cVDPV) by understanding oral polio vaccine (OPV) community circulation is increasingly important. Mexico, where OPV is given only during biannual national immunization weeks (NIWs) but where children receive inactivated polio vaccine (IPV) as part of their primary regimen, provides a natural setting to study OPV community circulation.

methodsIn total, 216 children and household contacts in Veracruz, Mexico, were enrolled, and monthly stool samples and questionnaires collected for 1 year; 2501 stool samples underwent RNA extraction, reverse transcription, and real-time polymerase chain reaction (PCR) to detect OPV serotypes 1, 2, and 3.

resultsOPV was detected up to 7 months after an NIW, but not at 8 months. In total, 35% of samples collected from children vaccinated the prior month, but only 4% of other samples, contained OPV. Although each serotype was detected in similar proportions among OPV strains shed as a result of direct vaccination, 87% of OPV acquired through community spread was serotype 2 (P < .0001).

conclusionsSerotype 2 circulates longer and is transmitted more readily than serotypes 1 or 3 after NIWs in a Mexican community primarily vaccinated with IPV. This may be part of the reason why most isolated cVDPV has been serotype 2.

Indexed as

National Health ProgramsAdolescentAdultChildChild, PreschoolFecesFemaleHumansLongitudinal StudiesMaleMexicoPoliomyelitisPoliovirusPoliovirus Vaccine, OralRural PopulationUrban PopulationPoliovirus Vaccine, Oralinactivated polio vaccineMexicooral polio vaccinepolioVDPV

Identifiers

PMID24367038
PMCPMC4017366
OpenAlexW1964619188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.